R
Ruibin Su
Publications - 7
Citations - 12
Ruibin Su is an academic researcher. The author has contributed to research in topics: Medicine & Chemistry. The author has an hindex of 2, co-authored 7 publications receiving 12 citations.
Papers
More filters
Journal ArticleDOI
Gs signaling pathway distinguishes hallucinogenic and nonhallucinogenic 5-HT2AR agonists induced head twitch response in mice.
TL;DR: In this paper , the authors found that 5-HT2A receptor coupled both Gs and Gq protein under hallucinogenic agonists DOM and 25CN-NBOH stimulation, but non-hallucinogenic drug TBG only activates Gq signaling.
Journal ArticleDOI
Rearing behaviour in the mouse behavioural pattern monitor distinguishes the effects of psychedelics from those of lisuride and TBG
TL;DR: This article examined the effects of phenylalkylamine and indoleamine psychedelics on locomotor activity and exploratory behavior using the mouse Behavioural Pattern Monitor (BPM).
Journal ArticleDOI
Tyrosine 7.43 is important for mu-opioid receptor downstream signaling pathways activated by fentanyl
TL;DR: Molecular docking was used to predict the amino acid sites that affect the binding of ligands and MOR and mutated to determine the effect of the structural determinant of MOR on Gi/o protein and ß-arrestin pathways, which may be responsible for the enhanced fentanyl analgesia.
Journal ArticleDOI
Contrasting effects of DOI and lisuride on impulsive decision-making in delay discounting task
TL;DR: Intervention of impulsive decision-making in male Sprague–Dawley rats was evaluated by the percentage of choice for the LR in delay discounting task (DDT), and DOI and lisuride have contrasting effects on impulsive decided-making via distinct receptors.
Journal ArticleDOI
Effects of Ketanserin, M100907 and Olanzapine on hallucinogenic like action induced by 2,5-dimethoxy-4-methylamphetamine
Xiao-Yan Liu,Mei Zhang,Ruibin Su +2 more
TL;DR: In this article , the effects of three 5-HT2A receptor antagonists (Kaneirn, M100907 and olanzapine) on hallucination-like behavior in therapeutic and preventive administration with male C57BL/6J mice were evaluated.